Information for the public
Other NICE guidance
-
Pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib (2015) NICE technology appraisal guidance 338
-
Neuropathic pain in adults: pharmacological management in non-specialist settings (2013) NICE guideline CG173
-
Osteoporosis: assessing the risk of fragility fracture (2012) NICE guideline CG146
-
Palliative care for adults: strong opioids for pain relief (2012) NICE guideline CG140
-
Patient experience in adult NHS services (2012) NICE guideline CG138
-
Bortezomib and thalidomide as first treatments for multiple myeloma (2011) NICE technology appraisal guidance 228
-
Lenalidomide for multiple myeloma in people who have had previous treatment (2009) NICE technology appraisal guidance 171
-
Metastatic spinal cord compression in adults: diagnosis and management (2008) NICE guideline CG75
-
Bortezomib monotherapy for relapsed multiple myeloma (2007) NICE technology appraisal guidance 129
-
Improving outcomes in children and young people with cancer (2005) NICE cancer service guidance 7
-
Improving outcomes in haematological cancers (2003) NICE cancer service guidance 3
ISBN: 978-1-4731-1660-3